djr-1.1 Antibody

What is the correct molecular weight for DJR-1.1 protein detection in Western blots?

When performing Western blot analysis for DJR-1.1, researchers should expect to observe a band at approximately 22 kDa under reducing conditions, representing the monomeric form of the protein. Under non-reducing conditions, a band at approximately 45 kDa may be observed, corresponding to the dimeric form of DJ-1 homologs .

To ensure accurate detection:

• Always include appropriate molecular weight markers

• Run samples under both reducing and non-reducing conditions to properly characterize protein state

• Include positive controls (recombinant DJR-1.1) and negative controls (lysates from djr-1.1 knockout animals)

It is worth noting that dimerization patterns observed with DJ-1 homologs can be affected by oxidative modification and glutathionylation .

How should I validate DJR-1.1 antibody specificity?

Validation of DJR-1.1 antibody specificity is critical for ensuring reproducible results. Implement the following methodological approach:

• Perform Western blots using:

  • Wild-type C. elegans lysates

  • djr-1.1 knockout lysates (should show no band)

  • djr-1.2 knockout lysates (should still show DJR-1.1 band)

  • Recombinant DJR-1.1 protein as positive control

• Implement immunodepletion experiments:

  • Pre-incubate antibody with recombinant DJR-1.1 protein

  • Use depleted antibody in parallel with non-depleted antibody

  • Specific signal should be significantly reduced with depleted antibody

• Conduct cross-reactivity testing:

  • Test against recombinant DJR-1.2 protein

  • Test against human DJ-1 protein to assess species specificity

As noted in research on antibody validation, approximately 50% of commercial antibodies fail to meet basic standards for characterization , making rigorous validation essential.

What sample preparation methods are optimal for DJR-1.1 immunodetection?

For optimal DJR-1.1 immunodetection from C. elegans samples:

• Tissue lysis buffer composition:

  • 50 mM Tris-HCl (pH 7.4)

  • 150 mM NaCl

  • 1% Triton X-100

  • 0.5% sodium deoxycholate

  • Protease inhibitor cocktail

  • Add 5-10 mM DTT if studying glutathionylation status

• Processing steps:

  • Homogenize worms in buffer (1:5 w/v ratio)

  • Centrifuge at 14,000 × g for 15 minutes at 4°C

  • Collect supernatant and determine protein concentration

  • Add reducing agent to half of the sample (for comparative analysis)

• Storage considerations:

  • Aliquot samples to avoid freeze-thaw cycles

  • Store at -80°C for long-term storage

  • Avoid sample oxidation which can affect epitope recognition

Research has shown that sample preparation can significantly impact detection of post-translational modifications, especially glutathionylation of DJ-1 homologs .

How does glutathionylation affect DJR-1.1 antibody recognition?

Glutathionylation of DJ-1 homologs can significantly impact antibody recognition in immunoassays. This post-translational modification alters protein conformation and can mask epitopes recognized by certain antibodies.

Research findings indicate:

• Glutathionylated DJ-1 can be detected using anti-GSH antibodies, showing a band at approximately 45 kDa under non-reducing conditions

• Treatment with 100 mM DTT abolishes reactivity with anti-GSH antibodies but maintains reactivity with anti-DJ-1 antibodies

• Certain epitopes may be masked or revealed depending on glutathionylation status

For experimental approaches:

• Use parallel immunoblotting with anti-DJR-1.1 and anti-GSH antibodies

• Prepare samples under both reducing and non-reducing conditions

• Consider using mutants of specific cysteine residues (Cys53 and Cys106 are preferentially glutathionylated in DJ-1)

This approach allows for comprehensive characterization of DJR-1.1 glutathionylation status, which may be particularly relevant in oxidative stress studies.

What are the methodological considerations for DJR-1.1 immunoprecipitation studies?

When performing immunoprecipitation (IP) of DJR-1.1 from C. elegans lysates:

• Antibody coupling strategy:

  • Direct coupling to protein A/G beads using crosslinkers like BS3 or DMP

  • Pre-clearing lysates with protein A/G beads alone to reduce non-specific binding

  • Using at least 2-5 μg antibody per 500 μg total protein

• IP buffer optimization:

  • Standard IP buffer: 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40

  • For studying protein-protein interactions: reduce detergent to 0.1-0.3%

  • For studying glutathionylation: add 1 mM EDTA and avoid reducing agents

• Elution and analysis:

  • Non-reducing elution for glutathionylation studies

  • Analysis by western blot with anti-DJR-1.1 and interaction partner antibodies

  • Mass spectrometry for unbiased identification of binding partners

It's critical to include appropriate controls:

• IgG control IP to identify non-specific binding

• IP from djr-1.1 knockout lysates to confirm specificity

• Input control (5-10% of starting material)

Research has demonstrated that IP followed by non-reducing SDS-PAGE can effectively preserve glutathionylated forms of DJ-1 homologs .

How can I distinguish between DJR-1.1 and DJR-1.2 in experimental systems?

Distinguishing between DJR-1.1 and DJR-1.2 is crucial for accurate interpretation of results in C. elegans studies. Implement these methodological approaches:

• Antibody-based discrimination:

  • Use epitope-mapped antibodies targeting unique regions

  • Validate antibody specificity using recombinant proteins and knockout controls

  • Consider generating peptide-specific antibodies against divergent regions

• Expression pattern analysis:

  • DJR-1.1 is predominantly expressed in intestine

  • DJR-1.2 is expressed in dopaminergic neurons

  • Use tissue-specific promoters (Pdat-1 for dopaminergic neurons) for transgene expression

• Functional discrimination:

  • DJR-1.2 knockout shows impaired dopamine-dependent behavior

  • DJR-1.2 interacts with LRRK2 in dopaminergic neurons

  • DJR-1.1 function is focused in the intestine

Research has shown that these DJ-1 homologs have distinct expression patterns and functional roles that can be leveraged for experimental discrimination .

What experimental approaches can assess the relationship between glutaredoxin and DJR-1.1?

To investigate the relationship between glutaredoxin (GLRX-10 in C. elegans) and DJR-1.1:

• Genetic interaction studies:

  • Generate glrx-10−/−; djr-1.1−/− double mutants

  • Compare phenotypes with single mutants to assess epistatic relationships

  • Create transgenic rescue lines expressing DJR-1.1 in glrx-10−/− background

• Biochemical interaction analysis:

  • Co-immunoprecipitation to detect physical interactions

  • Analysis of DJR-1.1 glutathionylation status in glrx-10−/− animals

  • In vitro deglutathionylation assays with recombinant proteins

• Functional assays:

  • Measure redox status in different genetic backgrounds

  • Assess oxidative stress resistance

  • Quantify protein levels of DJR-1.1 in glrx-10−/− animals

Research has demonstrated that loss of Grx1 results in decreased DJ-1 protein content in vivo in mice , suggesting a conserved relationship that may extend to C. elegans homologs.

How can I optimize immunofluorescence protocols for DJR-1.1 detection in C. elegans?

For optimal immunofluorescence detection of DJR-1.1 in C. elegans:

• Fixation and permeabilization:

  • 4% paraformaldehyde fixation for 30 minutes at room temperature

  • Permeabilization with 0.1% Triton X-100 for 10 minutes

  • Reduction with 1 mM DTT if studying reduced forms (avoid for glutathionylation studies)

• Antibody incubation parameters:

  • Primary antibody dilution: 1:100 to 1:500 in blocking buffer

  • Incubation time: overnight at 4°C

  • Secondary antibody: fluorophore-conjugated anti-species IgG at 1:1000 dilution

• Tissue-specific considerations:

  • For intestinal tissue (primary DJR-1.1 location), ensure proper permeabilization

  • Use counter-staining with intestine-specific markers

  • When examining neuronal tissues, focus on DJR-1.2 expression patterns

• Controls and validation:

  • Include djr-1.1−/− samples as negative controls

  • Use transgenic animals expressing fluorescently-tagged DJR-1.1 as positive controls

  • Perform peptide competition assays to confirm specificity

Methodologies used for fluorescence microscopy analysis in similar studies have shown that quantification of fluorescence intensity ratios provides reliable comparative data for protein expression levels .

Why might I observe inconsistent DJR-1.1 antibody performance across different applications?

Inconsistent antibody performance across applications (e.g., Western blot vs. immunoprecipitation vs. immunofluorescence) can occur for several methodological reasons:

• Epitope accessibility issues:

  • Protein folding differs in native vs. denatured states

  • Different fixation methods may preserve or alter epitopes

  • Post-translational modifications may mask epitopes

• Buffer and reagent incompatibilities:

  • Detergent concentrations affect protein conformation

  • pH variations can alter epitope structure

  • Reducing agents may disrupt disulfide bonds critical for epitope structure

• Validation approach:

  • For each application, perform titration experiments (1:100 to 1:5000 dilutions)

  • Test multiple antibody clones targeting different epitopes

  • Validate with both positive controls (recombinant protein) and negative controls (knockout samples)

Studies have shown that approximately 50% of commercial antibodies fail to meet basic standards for characterization , highlighting the importance of application-specific validation.

What methodological approaches can resolve contradictory findings in DJR-1.1 research?

When faced with contradictory results in DJR-1.1 research:

• Antibody validation strategy:

  • Compare results using multiple antibodies targeting different epitopes

  • Verify findings using genetic approaches (knockout/knockdown/overexpression)

  • Confirm protein identity by mass spectrometry analysis

• Experimental variable assessment:

  • Age of C. elegans populations (protein expression changes with age)

  • Oxidative stress conditions (affects glutathionylation status)

  • Strain background differences (genetic modifiers)

• Cross-laboratory validation:

  • Standardize protocols, including buffer compositions and incubation times

  • Exchange key reagents between laboratories

  • Perform blinded analyses when possible

• Complementary techniques:

  • Validate protein-protein interactions using multiple methods (IP, proximity ligation assay, FRET)

  • Confirm localization with both antibody staining and fluorescent protein tagging

  • Verify functional effects through multiple phenotypic assays

These comprehensive approaches help resolve contradictions that may arise from methodological differences or biological variability.

How should I design experiments to study DJR-1.1 and DJR-1.2 functional redundancy?

To systematically investigate potential functional redundancy between DJR-1.1 and DJR-1.2:

• Genetic approach:

  • Generate and characterize single knockouts (djr-1.1−/− and djr-1.2−/−)

  • Create double knockout (djr-1.1−/−; djr-1.2−/−)

  • Develop tissue-specific rescue lines expressing each protein in various backgrounds

• Experimental design for phenotypic analysis:

  Genetic Background	Intestinal Phenotypes	Neuronal Phenotypes	Oxidative Stress Response
  Wild-type	Baseline measurement	Baseline measurement	Baseline measurement
  djr-1.1−/−	Primary effect	Minimal effect	Partial effect
  djr-1.2−/−	Minimal effect	Primary effect	Partial effect
  Double knockout	Enhanced effect	Enhanced effect	Maximal effect
  djr-1.1 rescue	Rescue in intestine	Minimal rescue	Partial rescue
  djr-1.2 rescue	Minimal rescue	Rescue in neurons	Partial rescue

• Biochemical comparison:

  • Protein structure analysis of both homologs

  • Substrate specificity and binding partner identification

  • Post-translational modification patterns

Research has demonstrated that these DJ-1 homologs have distinct expression patterns but may share conserved biochemical functions related to oxidative stress response and protein quality control .

How can I use active learning approaches to improve antibody characterization for DJR-1.1?

Recent advances in active learning methodologies can enhance antibody characterization for DJR-1.1:

• Systematic epitope mapping:

  • Peptide array analysis to identify linear epitopes

  • Structural analysis to predict conformational epitopes

  • Alanine scanning mutagenesis to identify critical binding residues

• Machine learning implementation:

  • Apply algorithms to predict cross-reactivity based on sequence homology

  • Utilize active learning strategies to iteratively improve antibody specificity testing

  • Incorporate binding data from library-on-library approaches

• Experimental design optimization:

  • Develop strategic testing panels that minimize experimental resources

  • Implement iterative validation approaches guided by machine learning predictions

  • Reduce the number of required experiments by 28-35% compared to random sampling

Research has shown that active learning strategies can significantly improve experimental efficiency in antibody characterization by reducing the number of required experiments while maintaining or enhancing predictive accuracy .

What are the considerations for using DJR-1.1 antibodies in multiparametric analyses?

When incorporating DJR-1.1 antibodies into multiparametric analyses:

• Antibody compatibility assessment:

  • Test for cross-reactivity with other primary antibodies (especially when from the same host species)

  • Evaluate secondary antibody cross-reactivity

  • Perform single-stain controls to establish baseline signals

• Multiplexing strategies:

  • Sequential staining for co-localization studies

  • Tyramide signal amplification for weak signals

  • Direct conjugation of primary antibodies with different fluorophores to avoid secondary antibody conflicts

• Analysis optimization:

  • Establish appropriate compensation matrices for spectral overlap

  • Implement controls for autofluorescence, especially in intestinal tissue

  • Use quantitative image analysis software for co-localization studies

Research has demonstrated that proper antibody characterization is critical for reproducible multiparametric analyses and that inadequate validation can lead to misinterpretation of results in complex assays .

What emerging technologies will improve DJR-1.1 antibody research?

Several emerging technologies show promise for advancing DJR-1.1 antibody research:

• Recombinant antibody technologies:

  • Single-chain variable fragments (scFvs) for improved penetration in tissues

  • Nanobodies derived from camelid antibodies for accessing restricted epitopes

  • Genetically encoded intrabodies for tracking DJR-1.1 in living cells

• Advanced detection systems:

  • Super-resolution microscopy to visualize subcellular localization

  • Mass cytometry (CyTOF) for highly multiplexed protein detection

  • Proximity labeling approaches (BioID, APEX) to identify interaction partners

• CRISPR-based approaches:

  • Endogenous tagging of DJR-1.1 to avoid antibody-based detection

  • Generation of precise point mutations to study post-translational modifications

  • Creation of conditional alleles to study tissue-specific functions

These technologies will help address current limitations in antibody-based detection and provide complementary approaches for studying DJR-1.1 biology in C. elegans models of neurodegenerative disease.

How do I interpret contradictory results from different DJ-1 homolog antibodies?

When confronted with contradictory results from different antibodies against DJ-1 homologs:

• Systematic investigation approach:

  • Characterize each antibody's epitope and potential for cross-reactivity

  • Test each antibody against recombinant DJR-1.1, DJR-1.2, and human DJ-1

  • Validate findings with genetic approaches (knockout controls)

• Technical considerations:

  • Different fixation methods may preserve different epitopes

  • Buffer conditions can affect antibody performance

  • Post-translational modifications may mask specific epitopes

• Biological context evaluation:

  • Expression patterns differ between DJR-1.1 (intestine) and DJR-1.2 (neurons)

  • Glutathionylation status varies across tissues and stress conditions

  • Age-dependent changes in expression or modification